Director, Advanced Therapies CMO Enablement Technology

Director, Advanced Therapies CMO Enablement Technology

Join to apply for the Director role at Johnson & Johnson Innovative Medicine.

Locations:
Raritan, NJ;
Titusville, NJ;
Horsham, PA.

Johnson & Johnson Innovative Medicine is currently recruiting for a Director, Advanced Therapies CMO (Contract Manufacturing Organization) Enablement Technology, located in Raritan, NJ;
Titusville, NJ; or Horsham, PA to support the cell therapies business working with the growth and partnerships team.

This position will be a part of the Advanced (Use the "Apply for this Job" box below). Journey Orchestration team that provides technology solutions, strategies, and project execution for the cell and gene therapies business. In this capacity, the technology leader is expected to provide leadership around solution experience and roadmap, relationship management, project/program management, business process improvement, quality, and compliance. The position requires direct interaction with internal and external partners and technology colleagues to understand the capabilities and process requirements for cell therapy across all functional areas (Commercial, Clinical, Supply Chain, Medical Affairs, Quality).

Responsibilities

• Represent JJT in a leadership role to define solution approach and technologies, plan for implementation, and be responsible for the delivery and support of all technology tactics.
• Partner with external and internal manufacturing partners to execute technology enablement and roadmap development.
• Support integration and collaboration with TranSCend ERP program.
• Work with JJT product group leaders across Innovative Medicine Supply Chain and AT Supply Chain.
• Monitor and maintain progress on all key project phases utilizing existing tools and methodologies; establish and run the technology program governance to ensure clear accountability decision making, and consolidated view of project plans, financials, risks and issues.
• Responsible for technology budgets, resources, and delivery timelines.
• Structure vendor relationships and evaluate proof-of-concept projects that demonstrate value and validate user needs to deliver a reliable and seamless customer experience.
• Understand and explain external customer perspectives, internal partner needs, market opportunities, industry benchmarks, and system connections/constraints to ensure value creation and process efficiencies.
• Ensure that J&J information assets are appropriately identified, valued and protected according to local laws and worldwide security policies.
• Lead vendor partners and cross-JJT core-team on the definition, planning, and execution of current and future state needs for cell therapy related technology platforms and solutions.
• Implement and evolve program governance structure to ensure clear accountability decision making, leading to a single consolidated view of project plans, financials, risks and issues for the solution ecosystem.

Qualifications

• Bachelor’s degree is required.
• 15 years of IT experience is required.
• Business Experience.
• Life sciences or health care industry experience is required.
• Knowledge/experience with Oncology/Cell & Gene Therapy is preferred.
• Experience with supply chain business (Manufacturing, Planning/Deliver, Quality, Procurement) is required.
• Experience with SAP/ERP deployment required.
• Project Management experience delivering large scale technology projects from concept through delivery and operations is required.
• 10 years of people management experience is required.

Base Pay Range
: $150,000 - $258,750

Johnson & Johnson is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, age, national origin, disability, protected veteran status or other characteristics protected by federal, state or local law. We actively seek qualified candidates who are protected veterans and individuals with disabilities as defined under VEVRAA and Section 503 of the Rehabilitation Act.